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AKTIVITI ANTIOKSIDAN, ANTI-ANGIOGENIK DAN ANTI-INFLAMASI 
EKSTRAK TERPIAWAI DAUN GYNURA SEGETUM 
 
ABSTRAK 
 
Gynura segetum (daun dewa dalam bahasa Malaysia) ialah herba, dipercayai berguna 
untuk rawatan kanser dan inflamasi.  Dalam kajian ini, aktiviti anti-inflamasi atas 
ekstrak terpiawai daun Gynura segetum dan juga kemungkian hubungan dengan 
aktiviti antioksidan, anti-angiogenik dan sitotoksik telah disiasat.  Fraksi etil asetat 
menunjukkan aktiviti antioksidan yang terkuat berdasarkan asai memerangkap DPPH 
dan asai kapasiti pelunturan beta karotena dan berkaitan terus dengan jumlah 
kandungan fenolik dan flavonoid. Ekstrak metanol adalah yang paling aktif dalam 
menghalang pertumbuhan saluran darah dalam asai anak ayam embrio membran 
korioalantoik (CAM) dan asai aorta tikus cincin. Ini menunjukkan ia mempunyai 
aktiviti anti-angiogenik.  Ekstrak metanol tidak sitotoksik dan penyekatan aktiviti 
faktor pertumbuhan endotel vaskular (VEGF) adalah salah satu mekanisme tindakan 
untuk anti-angiogenik.  Ekstrak metanol mempunyai aktiviti anti-inflamasi kerana ia 
menghalang kerengsaan oleh SDS-teraruh dalam ujian telur ayam membran 
korioalantoik (HET-CAM) dan pembentukan granuloma dalam asai pelet kapas-
teraruh granuloma pada tikus.  Aktiviti anti-inflamasi ekstrak metanol ditunjukkan 
melalui perencatan pada tahap pro-inflammasi sitokin tumor nekrosis faktor-α (TNF-
α), interleukin-1 (IL-1) dan enzim siklooksigenase-2 (COX-2).  Oleh itu, penemuan 
daripada kajian ini mencadangkan bahawa daun Gynura segetum adalah sumber 
antioksidan semula jadi dan mempunyai aktiviti anti-angiogenik yang mungkin 
menjelaskan aktiviti anti-inflamasi kronik dan potensi dalam anti-kanser. 
 xxiii 
ANTIOXIDANT, ANTI-ANGIOGENIC AND ANTI-INFLAMMATORY 
ACTIVITIES OF STANDARDIZED GYNURA SEGETUM LEAF EXTRACTS  
 
ABSTRACT 
 
Gynura segetum (daun dewa in Malay) is a herb, reputed of value among others for 
treatment of inflammation and cancer. In the present study, the anti-inflammatory 
activity of the standardized leaf extracts of Gynura segetum were investigated as well 
as its possible relation to antioxidant, anti-angiogenic and cytotoxic activities. The 
ethyl acetate fraction showed the strongest antioxidant activity based on DPPH 
scavenging activity and beta carotene bleaching capacity assays and directly related 
to its total phenolic and flavonoid contents.  The methanol extract was the most 
active in inhibiting the blood vessels growth in chick embryo chorioallantoic 
membrane (CAM) assay and rat aortic ring assay. It shows it has anti-angiogenic 
activity. It is non-cytotoxic and suppression of vascular endothelial growth factor 
(VEGF) activity is one of the anti-angiogenic mechanisms of action. The methanol 
extract possesses anti-inflammatory activity as it inhibited SDS-induced irritation in 
hen’s egg chorioallantoic membrane (HET-CAM) test and cotton pellet-induced 
granuloma formation in rat. Its anti-inflammatory activity is mediated through the 
inhibition of pro-inflammatory cytokines tumor necrosis factor-α (TNF-α) and 
interleukin-1 (IL-1) and cycloxygenase-2 (COX-2) enzyme activities.  Taken 
together, the present study suggests that Gynura segetum’s leaf is a natural source of 
antioxidants and possesses anti-angiogenic activity which may explain its chronic 
anti-inflammatory activity and anti-cancer potential. 
1 
 
CHAPTER 1 
INTRODUCTION 
 
1.1 Background  
Herbal medicines are the therapeutic experiences of generations of practicing 
physicians of traditional medicine over hundreds of years and they are known to be 
oldest health care products that have been used by mankind all over the world to treat 
various types of ailments (Torey et al., 2010).   
 
The demand for medicine from plants has increased and the global awakening of 
herbal medicines is also reflected in Malaysia.  Medicinal plants grown in Malaysia 
have also received attention as new resources for alternative medicines over the past 
years (Sone et al., 2011).  Currently, attention is being focused on the investigation 
of the efficacy of traditionally used plants as they are affordable and have fewer 
adverse effects (Masresha et al, 2012).  
 
Gynura segetum, from family Compositae is a cultivated species and can be found 
growing in the tropical regions in Indonesia and Malaysia.  G. segetum has drawn a 
lot of attention due to its uses in traditional medicine. The plant is known for its 
traditional use for the treatment of cancer, inflammation, diabetes, hypertension and 
skin afflictions.  A variety of chemical compounds have been identified from this 
genus such as flavonoids, pyrolizidine alkaloids, triterpenes, steroids and 
sesquiterpenoids (Zhu et al., 2013).  In spite of numerous phytochemical studies, 
there has been no systematic approach to understanding the ethno pharmacological 
activity of this plant.     
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In previous study, crude leaf extracts of G. segetum showed potential anti-angiogenic 
effect in chick embryo chorioallantoic membrane (CAM) model (Seow, 2010).  Anti-
angiogenic strategies are emerging as an important tool for the treatment of cancer 
and inflammatory diseases.  Angiogenesis and inflammation are codependent 
processes, which involves both augmentation of cellular infiltration and proliferation 
and overlapping roles of regulatory growth factors and cytokines (Jackson et al., 
1997).  Many compounds that inhibit angiogenesis have also shown to block 
inflammatory responses due to this interconnection. 
 
Angiogenesis in inflammatory diseases contribute to tissue growth, disordered tissue 
perfusion, abnormal ossification (formation of bony substance) and enhanced 
responses to normal or pathological stimuli (Walsh and Pearson, 2001).  
Angiogenesis inhibitor may reduce inflammation and also help to restore appropriate 
tissue structure and function.  Most of the research on anti-angiogenic agents has 
been directed towards inflammation treatment (Kim et al., 2004; Ahn et al., 2007; 
Jung et al., 2009; Krenn and Paper, 2009).  Collectively, this suggested that many 
herbs and their phytochemicals may exert both anti-angiogenic effects and anti-
inflammatory activity.  Thus, there is an interest to discover local medicinal plant for 
anti-angiogenic and anti-inflammatory effects. 
 
Hence, the present study was carried out to expand the study on the anti-angiogenic 
and anti-inflammatory activities of the various extracts and fractions of G. segetum’s 
leaf, and investigate the probable mechanism of action of the most active 
extract/fraction.  Standardization of the G. segetum’s leaf extract by chemical 
profiling (High performance thin layer chromatography), quantification of two 
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marker compounds using a validated HPLC (high performance liquid 
chromatography) method and biological profiling (determination of total phenolic 
and flavonoids content, and antioxidant activity) were also carried out.  The 
experiments of the present study were summarized in Figure 1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
 
 
Figure 1.1: Flow chart of antioxidant, anti-angiogenic and anti-inflammatory activities of standardized Gynura segetum leaf extracts
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1.2 Problem of Statements 
Gynura segetum from family Compositae was claimed to possess various medicinal 
values including possible treatment of cancer, diabetes, inflammation and 
hypertension (Suharmiati and Maryani, 2003).  Although this plant is traditionally 
used in treatment of cancer and inflammatory disorders, but to the best of our 
knowledge, its anti-cancer potential and anti-inflammatory activity has not yet been 
confirmed scientifically.  The present studies focus on both in vivo and in vitro anti-
angiogenic and anti-inflammatory activities in order to further investigate the 
potential of this plant.   The standardization and antioxidant activities of the G. 
segetum’s leaf extract were also performed to evaluate its possible relation to the 
anti-angiogenic and anti-inflammatory activities.   
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1.3 Objectives  
The objectives of the present study are: 
1. To standardize the G. segetum leaf extracts by using phytochemical and 
chromatographic methods (HPTLC and HPLC).  
2. To evaluate antioxidant potential of standardized leaf extracts of G. segetum 
by using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity 
and beta-carotene-linoleate model assays and their correlation with total 
phenolic and flavonoid content. 
3. To determine the anti-angiogenic activity of standardized leaf extracts of G. 
segetum by different experimental models (in vivo chicken chorioallantoic 
membrane assay and ex vivo rat aortic ring assay) and their possible 
mechanism of action. 
4. To study the in vivo anti-inflammatory effects of standardized leaf extracts of 
G. segetum by different experimental models (hen’s egg chorioallantoic 
membrane test and cotton pellet granuloma model in rats) and their possible 
mechanism of action. 
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CHAPTER 2 
LITERATURE REVIEWS 
 
2.1 Description of Gynura segetum (Lour.) Merr. 
G. segetum from family Compositae is a cultivated species and can be found growing 
in the tropical regions in Indonesia and Malaysia.  The leaves are shortly petiole, 
fleshy with serrated margin and both surfaces are pubescent (Figure 2.1).  The upper 
surface is green and lower surface is purplish green.  The stem branches profusely, 
purplish green in color and slightly hairy.  The yellowish orange flowers have a 
strong and foetid odour.  The plants produce numerous roots which are attached to a 
tuber.  The plants collected from Jabatan Pertanian Relau, Penang were identified by 
the botanist (Mr. V. Shanmugan) from School of Biological Sciences, Universiti 
Sains Malaysia and a voucher specimen has been deposited at the herbarium of 
School of Biological Sciences, University Sains Malaysia with reference number 
11013. 
 
Figure 2.1: Gynura segetum (Lour.) Merr 
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2.2 Previous studies on Gynura segetum  
A literature survey indicated that lack of research on G. segetum plant.  To date, only 
few investigations on phytochemical studies of G. segetum have been reported.  The 
structures of some isolated compounds of G. segetum are shown in Figure 2.2. 
 
Alkaloid compound senecionine was elucidated and reported by Liang et al. (1984).  
Succinic acid, D-mannitol, thymine, adenine and pyrrolizidine alkaloids were 
isolated and identified by Liu et al. (1988) from aerial portion of G. segetum plant.  
Six alkaloids were isolated by Yuan et al. (1990) and four of them were identified as 
follows: senecionine, seneciphylline and seneciphyllinine.  In Yang et al. (2009), a 
rapid reversed-phase high-performance liquid chromatographic (RP-HPLC) method 
was established for simultaneous determination of senecionice, seneciplylline and 
senecionine N-oxide in G. segetum.     
 
Zhu et al. (2013) reported the isolation of nine new compounds from G. segetum for 
the first time.  Their structures were identified to be stigmasterol, isoarborinol, 
arborinol, zhebeiresinol, lumichrome, (2S,3S,4R,8E)-2-[(2R)-2-
hydroxypalmitoylamino]-8-octadecene-1.3.4-triol, syringic acid, vanillic acid, trans-
p-hydroxycinnamic acid on the basis of mass and NMR spectra.   
 
Previous study demonstrated that the leaf extracts of G. segetum inhibited the 
sprouting of blood vessels growth in chick embryo chorioallantoic membrane (CAM) 
model.  The anti-angiogenic activity of G. segetum provided a pharmacological basis 
on its folkloric  
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Figure 2.2: Chemical structures of some isolated compounds of Gynura segetum 
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use for the treatment of inflammatory diseases and cancer (Seow, 2010).  Angiogenic 
factors have a central role in promoting cancer and a strategic position in the 
regulation of angiogenesis, eventually stimulating endothelial cells that are 
genetically stable in comparison with the genetically labile tumor cells (Schenone et 
al., 2007).  New blood vessels can maintain the chronic inflammatory state by 
transporting inflammatory cells to the site of inflammation and supplying nutrients 
and oxygen to the inflamed tissue.  The inflamed tissues are induced to release large 
quantities of angiogenic factors (VEGF) and cytokines (Walsh and Pearson, 2001).  
Therefore, anti-angiogenic therapy is a promising approach for the treatment of 
cancer and other angiogenesis-dependent diseases i.e. chronic inflammation. 
 
Preliminary phytochemical screening revealed the presence of alkaloids, terpenes, 
flavonoids, tannins and saponins in leaves of G. segetum (Seow, 2010). On the other 
hand, the presence of phenolic compounds in the plants indicates that this plant may 
be anti-microbial agent and this agreed with the findings of Seow (2010).  Moreno et 
al. (2006) suggested that the antimicrobial action of phenolic compounds was related 
to inactivation of cellular enzymes, which depended on the rate of penetration of the 
substance into the cell or caused by membrane permeability changes. Increased 
membrane permeability is a major factor in the mechanism of antimicrobial action, 
where phenolic compounds disrupt the membranes and causing loses of membrane 
permeability and eventually the death of cell (Cetin-Karaca, 2011).
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2.3 Standardization  
Standardization of herbal medicines means confirmation of its identity and 
determination of its quality and purity (Pandey and Tripathi, 2014).  Plants contain 
phytochemical that can be used for therapeutic purpose or as precursors for 
pharmaceutical synthesis.  The world market demand for herbs and their products has 
increased tremendously in recent years.  Therefore, methods for standardization of 
herbal raw materials and herbal formulations are developed.   
 
Pharmacopoeias carry monographs for herbs and herbal products to maintain their 
quality. Several pharmacopoeias including United States Pharmacopoeia, Indian 
Pharmacopoeia, European Pharmacopoeia, and British Pharmacopoeia do cover 
monographs and quality control tests for a few medicinal plants. There many changes 
are being incorporated into the different pharmacopoeias, as reflected by the 
availability, development, and subsequent refinement of analytical techniques 
(Rajani and Kanaki, 2008).  In the present study, the standardization and validation 
of analytical procedures were carried out according to the European Pharmacopoeia. 
 
Standardization of herbal medicines involves the collection of information and 
application of strict quality control measurement from the growing of a medicinal 
plant to the finished therapeutic substance (Garg et al., 2012).   The standardization 
of plant includes a complete description of the starting plant materials, control and 
monitoring of numerous factors namely growing conditions, harvesting time, 
harvested plant part, microscopy and macroscopic analysis, ash values and extractive 
values, moisture content determination, drying methods, storage, extraction process, 
chromatographic and analytical evaluation which are required for providing 
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consistency of the quality of an plant extract (Bele and Khale, 2011; Garg et al., 
2012).  
 
Most of the medicinal plants have definite specific chemical constituents to which 
their biological or pharmacological activity is attributed (Pandey and Tripathi, 2014).  
Pharmacological properties of a plant extract depend on phytochemical constituents 
present therein.  Without a consistent quality of a phytochemical mixture, a 
consistent pharmacological effect is not achieved (Mosihuzzaman and Choudhary, 
2008; Maiti et al., 2011).  Phytochemical standardization comprises all the possible 
information with regard to the chemical constituents present in herbal medicines. The 
phytochemical evaluations include preliminary screening for the presence of 
different chemical groups (e.g. alkaloids, flavonoids, saponins, triterpenic acids, 
tannins and etc.), quantification of chemical of interest and establishment of 
fingerprint profiles based upon single or multiple markers (Kulkarni et al., 2014). 
 
Chromatographic fingerprinting plays an important role in the quality control of 
complex herbal medicines (Kamboj and Saluja, 2013).  A fingerprint refers to the 
common peaks of chromatograms which can be used to characterize and determines 
the concentration of a set of characteristic chemical substances in an herb (Kulkarni 
et al., 2014).  Using this technique, the identification of various chemical markers of 
the herbal medicines can be easily done and it also serves as a tool for authentication 
and quality control of herbal drugs (Kasar et al., 2013).   
 
Chromatographic fingerprint of herbal medicine is a chromatographic pattern 
produced from extract of some specific chemical constituents which may be 
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pharmacologically active or have some chemical characteristics (Kulkarni et al., 
2014).  Standardized extracts are high-quality extracts containing consistent levels of 
specified marker/bioactive compounds (Bandaranayake, 2006).  There are two types 
of standardized extract, which are active constituent extract and marker compound 
extract.  Active constituent extract contains the constituents with known therapeutic 
effect which can be used to standardize a biological activity.  However, marker 
compound is not necessarily active compounds, as chemically defined constituents, 
which are used for control purpose (Kamboj and Saluja, 2013).   
 
Sensitivity is the major concern for the detection of various chemical markers in 
extract.  Thus, chromatographic techniques in combination with different detections 
are the preferred techniques.  High performance thin layer chromatography (HPTLC) 
and High performance liquid chromatography (HPLC) are suitable analytical method 
for the separation and quantitative determination of various chemical markers of 
herbal medicines.    
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2.3.1 High performance thin layer chromatography (HPTLC)  
HPTLC has recently emerged as an useful tool for fingerprinting and quantification 
of marker compounds in herbal medicines (Bala and Saini, 2013).  In its traditional 
form, thin layer chromatography has use in identification of botanical raw materials 
(Kasar et al., 2013).  The modern HPTLC offers better resolution which allows a 
quantitative analysis at micro and even in nano gram levels (Kamboj and Saluja, 
2013).  A wide spectrum of constituents can be detected at the same time in a single 
run in an experiment by HPTLC and the flexibility of detection are particularly 
useful for fingerprinting analysis.    
 
The modern HPTLC can generate a chromatographic fingerprint in the form of an 
unique sequence of peaks corresponding to the analyzed sample in its fullness 
(Nicoletti, 2011).  The resulted chromatogram can be evaluated based on number, 
sequence, color and relative position of zones (Rf) with respect to zone obtained on 
the same plate with chemical reference materials (Kasar et al., 2013).  The results are 
not only reported as peak data, but can also conveniently be presented as colorful 
images, their absorption spectra, λ max and shoulder inflections of all the resolved 
bands (Kamboj and Saluja, 2013).     
 
Collectively, fingerprinting of HPTLC is proved to be a linear and precise method 
for herbal identification and can be further used in authentication and 
characterization of the medicinally important plant (Sushma et al., 2013).  However, 
HPTLC method has few limitations, such as the limited developing distance and it is 
often not possible to obtained baseline separation of all components of such complex 
samples as medicinal plant materials (Kasar et al., 2013).  Also, the sensibility of 
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HPTLC is still not comparable with HPLC.  In HPTLC, two closely related 
compounds may not be appropriately resolved and hence migrate as a single peak.  
This situation would result into misleading results in quantitative analysis, especially 
if one of the non-resolved compounds is an unknown impurity or a degradation 
product (Hewala et al., 2012).  Therefore, most fingerprinting analysis is typically 
based on HPLC.      
 
2.3.2 High performance liquid chromatography (HPLC)  
 HPLC is one of the most important tools of analytical chemistry and widely used for 
fingerprinting study of herbal plants.  HPLC mainly utilizes a column that holds 
packing material (stationary phase), a pump that moves the mobile phase through the 
column, and a detector that shows the retention times of the molecules (Malviya et 
al., 2010).  The separation of sample is based on the differences in the rates of 
migration through the column arising from different partition of the sample between 
the stationary and mobile phase.  Depending upon the partition behavior of different 
components, elution at different time takes place (Gupta et al., 2012). 
 
Analytical method development and validation are key elements of any 
pharmaceutical development program (Singh, 2013).  HPLC analysis method is 
developed to ensure the identity, purity and quantification of the chemical 
constituents in herbal plant.  All analytical methods that are intended to be used for 
analyzing any chemical constituents in plant material will need to be validated 
(Gupta et al., 2012).  The validation practice demonstrated that an analytic method 
measures the correct constituent in correct quantity, and in the proper range for the 
intended samples (Julia et al., 2011; Khan et al., 2012).     
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The validation of analytical method is performed according to the ICH (International 
Conference on the Harmonization of Technical Requirements for the Registration of 
Pharmaceuticals for Human Use) guidelines (ICH, 2002).  The various validation 
parameters include linearity, accuracy, limits of detection and quantification (LOD 
and LOQ), precision, robustness and selectivity or specificity (Singh, 2013).    
 
Reproducible quality of HPLC results can only be obtained if proper attention has 
been paid to the method development, validation and system’s suitability to carry out 
the analysis (Singh, 2013).  The validated methods provide emerging knowledge 
supporting the standardization of herbal plant and the method could be utilized for 
quality check of various pharmaceutical and nutraceutical preparations developed 
from the herbal plants (Masresha et al., 2012).  The herbal plants will be earlier 
tested in animal experiments and further tested in a clinical study in order to prove its 
safety and efficacy. 
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2.4 Antioxidant  
Antioxidants are defined as molecules which can be safely interact with free radicals 
and terminate the chain reaction before vital molecules are damaged (Nidhi and 
Gauray, 2012).  Antioxidants can also be molecules which prevent or inhibit free 
radical formation, involved in the defense mechanism of the organism against the 
pathologies associated to the attack of free radicals (Pisoschi and Negulescu, 2011). 
 
Antioxidants can be derived from natural sources (vitamins, flavonoids, anthocyanins, 
some mineral compounds), but can also be synthetic compounds, like butylated 
hydroxyl anisole (BHA), butylated hydroxytoluene (BHT), propyl gallate (PG), etc 
(Pisoschi and Negulescu, 2011).  BHA and BHT are widely used in food industry as 
antioxidants in order to reduce the damage caused by free radicals.  However, the 
toxicological research demonstrated that these synthetic antioxidants possess toxic, 
pathogenic and carcinogenic effects (Ganie et al., 2011; Jiang et al., 2013).  
Therefore, interest in finding natural antioxidants from plant materials has drawn 
more and more attention (Safaei-Ghomi et al., 2009).      
 
The use of traditional medicine is widespread and plants are potential source of 
natural antioxidants that might serve as leads for the development of novel drugs 
(Conforti et al., 2008).  Plant-derived antioxidants have been shown to function as 
singlet and triplet oxygen quenchers, free radical scavengers, peroxide decomposers, 
enzyme inhibitors and synergists (Lai and Palanisamy, 2012).  Antioxidants such as 
the vitamins A, C and E, beta carotene, flavonoids, mineral selenium have potential 
to prevent oxidative damage and demonstrated their potent antioxidant activities both 
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in vitro and in vivo (Mokhtar et al., 2008; Pandey and Rizvi, 2009; Hamid et al., 
2010).    
 
2.4.1 The mechanism of actions of antioxidant  
Free radicals are considered as unstable molecule, which react quickly with other 
compounds, trying to capture the needed electron to gain stability (Nidhi and Gauray, 
2012).  Free radicals of highly reactive oxygen species (superoxide, O2˙  ; hydroxyl, 
OH˙; peroxyl, ROO˙; peroxinitrite, ˙ONOO   and nitric oxide, NO˙) produced 
through oxidative process (Abdel-Hameed, 2009).  Oxidative stress occurs when 
there is an imbalance between free radical reactions and the scavenging capacity of 
antioxidative defense mechanism of the organism (Seifu et al., 2012).  A number of 
biochemical processes can initiate oxidation, which proceeds continuously in the 
presence of (a) suitable substrate(s), until a blocking defense mechanism occurs 
(Pisoschi and Negulescu, 2011).  
 
Antioxidants are compounds or systems that delay autoxidation by inhibiting the 
formation of free radicals by several mechanisms: initiation, propagation, and 
termination (Hamid et al., 2010) as shown below.  The oxidation may be initiated by 
the action of external agents such as heat, light or ionizing radiation or by chemical 
initiation involving metal ions or metalloproteinase (Pisoschi and Negulescu, 2011). 
 
a)  Initiation: free radicals are formed from molecules that readily give up electrons. 
(1) RH → R˙+ H˙ 
(2) R˙ + O2 → ROO˙ 
(3) 2ROOH → ROO˙ + RO˙ + H2O 
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b) Propagation: the free radicals are alternately expended and formed. 
(1) R˙ + O2 → ROO˙ 
(2) ROO˙ + RH → ROOH + R˙ 
(3) RO˙ + RH → ROH + R˙ 
 
c) Termination: involve the combination of radicals to form non-radical products. 
(1) R˙ + R˙ → R – R 
(2) R˙ + ROO˙ → ROOR 
(3) ROO˙ + ROO˙ → ROOR + O2 
 
2.4.2 Methods of antioxidant activity assessment 
Antioxidants affect the process of lipid oxidation at different stages due to the 
differences in their mode of action (Ghasemzadeh et al., 2010).  There is no single 
method that can provide unequivocal measurement of antioxidant activity and the 
best solution is to use various methods instead of a one-dimension approach 
(Carocho and Ferreira, 2013).  
 
a) The 2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) method 
The ABTS assay is a colorimetric assay in which the ABTS radical decolorizes in the 
presence of antioxidants (carotenoids, phenolic compounds and others) (Moon and 
Shibamoto, 2009).   The ABTS cation radical (ABTS•+) which absorbs at 743 nm 
(giving a bluish-green colour) is formed by the loss of an electron by the nitrogen 
atom of ABTS.  In the presence of hydrogen donating antioxidant, the nitrogen atom 
quenches the hydrogen atom, yielding the solution decolorization (Pisoschi and 
Negulescu, 2011). 
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b) The 2,2-diphenyl-1-picrylhydrazyl (DPPH) method 
DPPH (2,2-diphenyl-1-picrylhydrazyl) is characterized as stable free radical and able 
to accept an electron or hydrogen radical (Kchaou et al., 2013).  This colorimetric 
assay uses the DPPH radical, which changes from purple to yellow in the presence of 
antioxidants (Moon and Shibamoto, 2009).  When DPPH reacts with a hydrogen 
donor, the reduced (molecular) form (DPPH) is generated, accompanied by the 
disappearance of the violet color. Therefore, the absorbance diminution depends 
linearly on the antioxidant concentration (Pisoschi and Negulescu, 2011). 
 
c) The ferric reducing antioxidant power (FRAP) method 
The FRAP method is characterized by the reduction of iron, Fe
3+
 to Fe
2+
 depending 
on the available reducing species followed by the alteration of color from yellow to 
blue and analyzed through a spectrophotometer (Antolovich et al., 2002).  Reducing 
power appears to be related to the extent of conjugation in phenols as well as the 
number of hydroxyl constituents (Schaich, 2006).  Further, the assay reaction must 
be carried out at acidic pH in order to maintain iron solubility (Craft et al., 2012).   
 
d) The oxygen radical absorption capacity (ORAC) assay 
This method measures the antioxidant scavenging activity against the peroxyl radical 
(ROO˙), induced by 2,2’-azobis-(2-amidino-propane) dihydrochloride (AAPH), at 
37ºC. Fluorescein is used as the fluorescent probe. The loss of fluorescence is an 
indicator of the extent of the decomposition, from its reaction with the peroxyl 
radical (Thaipong et al., 2006; Denev et al., 2010).  Any antioxidant species present 
in the reaction mixture will undergo hydrogen atom transfer mechanism with the 
peroxyl radicals and delay the reduction of the fluorescent signal (Craft et al., 2012). 
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e) The total radical-trapping antioxidant parameter (TRAP) assay 
The TRAP assay is used to determine the total antioxidant activity, based on 
measuring oxygen consumption during a controlled lipid oxidation reaction induced 
by thermal decomposition of AAPH (2,2’-Azobis(2amidinopropane)hydrochloride) 
(Antolovich et al., 2002).  The basic reactions of the assay are similar to those of 
ORAC.  The TRAP assay involves the initiation of lipid peroxidation by generating 
water-soluble peroxyl radicals and is sensitive to all known chain breaking 
antioxidants, but it is relatively complex and time-consuming to perform, requiring a 
high degree of expertise and experience (Prior et al., 2005). 
 
f) The cupric reducing antioxidant power (CUPRAC) assay 
The method relies on the reduction of copper, Cu (II) to Cu (I) by the antioxidants 
present in the sample. Then, bathocuproine (2,9-dimethyl-4,7-diphenyl-1,10-
phenanthroline) forms a complex with Cu (I) and has a maximum absorbance at 490 
nm (Huang et al., 2005).  Copper has a lower redox potential than iron, so its 
reactions are more selective e.g. sugars and citric acid which commonly interferences 
with iron in FRAP, are not oxidized in CUPRAC.  The low redox potential enhances 
redox cycling, so copper reduction may be an even more sensitive indicator of 
potential pro-oxidant activity of antioxidants (Prior et al., 2005).  
 
g) Beta-carotene linoleic acid method/conjugated diene assay 
The basis of the beta-carotene bleaching assay is the discoloration of beta-carotene in 
a reaction with a linoleic acid free radical. A radical is formed upon the removal of a 
hydrogen atom located between two double bonds in linoleic acid. Beta-carotene has 
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a maximum absorbance at 470 nm.  Antioxidants present in the reaction solution can 
prevent the degradation of beta-carotene (Fu et al., 2013).   
 
2.4.3 Herbal medicines and antioxidant activities  
To date, numerous of plants in Malaysia have been studied for their antioxidant 
activity.  Garcinia mangostana, Mangifera indica, Nephelium lappaceum, 
Anacardium occidentale, Piper betle and Syzygium aquem exhibit high antioxidant 
activity and proposed to be an alternative source of polyphenols (Mokhtar et al., 
2008; Lai and Palanisamy, 2012).  Compounds that have several or many phenolic 
hydroxyl substituents are often referred to as polyphenols, which have strong 
hydrogen atom donating activity to terminate the chain reactions of free radicals and 
inhibit oxidation (Maestri et al., 2006).   
 
An antioxidant activity has been reported in a number of Gynura species.  Caffeic 
acid and quercetin 3-O-rutinoside isolated from Gynura formosana Kiamnra were 
found to show good antioxidant activity against DPPH and hydroxyl radicals (Hou et 
al., 2005).  The antioxidant potency of Gynura procumbens leaves were investigated 
by Rosidah et al. (2008); Akowuah et al. (2009) and Shwter et al. (2014), suggest 
that phenolic compounds in these plants provide substantial antioxidant activity.  The 
Gynura medica leaf extract showed a moderate radical scavenging activity, which 
agreed with the moderate level of flavonoid compounds existing in the plant; 
kaempferol-3-O-glucoside was the major compound of the plant (Liu et al., 2010). 
Meanwhile, the ethyl acetate extract of Gynura bicolor with the highest total 
phenolic content among these species extracts generally showed the strongest ability 
in scavenging DPPH radicals and metal chelating activity (Teoh et al., 2013). 
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2.5 Angiogenesis  
Angiogenesis is a progressive, multistep physiological process by which new blood 
vessels are generated from pre-existing vasculature (Deryugina and Quigley, 2008).   
Angiogenesis plays a central role in various physiological processes within human 
body, such as, embryonic development, menstrual cycle, and wound repair. 
Unregulated angiogenesis is intensively involved in many pathological conditions 
including psoriasis, retinopathy and cancer and various ischemic and inflammatory 
diseases (Choe and Lee, 2007; Yoo and Kwon, 2013).   
 
The process of angiogenesis can be simply described into three major steps including:  
i) Initiation of the angiogenic response:  Angiogenesis is initiated in response to 
hypoxia, by the release of hypoxia inducible factors (HIF), which facilitate the 
release of angiogenic stimulators, which in turn lead to endothelial cell 
activation.  Activated endothelial cell secrete matrix metalloproteinases (MMPs) 
and plasminogen activators (PAs), which degrade the extracellular tissue to 
facilitate endothelial penetration. Both PAs and MMPs are secreted together 
with their inhibitors, ensuring a stringent control of local proteolytic activity 
(Bisht et al., 2010).  
 
ii) Endothelial cell migration, proliferation and tube formation: Extracellular matrix 
degradation results in an increased concentration of various growth factors, 
which stimulate endothelial cell migration and proliferation.  After the initial 
period of migration, rapid endothelial cell proliferation begins, thus increasing 
the rate of sprout elongation. These processes are also mediated by cell adhesion 
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molecules (Integrin αvβ3and αvβ5, vascular endothelial cadherin, vascular cell 
adhesion molecule-1, P-selectin, and E-selectin) (Bisht et al., 2010). 
 
iii) Maturation of the neovasculature: The final phase of the angiogenic process 
involves maturation of the neovasculature.  After endothelial cell proliferation 
and maturation, and the formation of endothelial tube structures, surrounding 
vessel layers composed of mural cells (pericytes in small vessels and smooth 
muscle cells in large vessels), need to be recruited. Endothelial cells may 
accomplish this via the synthesis and secretion of platelet-derived growth factor 
(PDGF), a mitogen and chemo attractant for a variety of mesenchyme cells. 
Subsequent differentiation of the mural precursor cells into pericytes and smooth 
muscle cells is believed to be a cell-cell contact dependent process (Grifﬁoen 
and Molema, 2000). Finally, when sufficient neovascularization has occurred, 
the angiogenic factors are down regulated or the local concentration of the 
inhibitors increases. As a result, the endothelial cells become quiescent (Bisht et 
al., 2010). 
 
2.5.1 Angiogenic factors and inhibitors 
Angiogenesis is a tightly controlled by a complex balance between the pro-
angiogenic and anti-angiogenic factors (Tahergorabi and Khazaei, 2012).  A number 
of endogenous angiogenic factors and inhibitors have been discovered and identified, 
that regulate the balance between the pro- and anti-angiogenic states (Carmeliet et al., 
2000).  Some of the most important factors and inhibitors are shown in Table 2.1. 
